Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Comparison of intranasal dexmedetomidine and oral midazolam as premedication for cochlear implant surgery in children

View through CrossRef
Background: Children undergoing surgical procedures can experience significant anxiety and distress during the perioperative period. The use of sedative premedication may help to reduce anxiety, minimize the emotional trauma, and facilitate a smooth induction of anesthesia. Midazolam is most commonly used as a premedication agent in children. Dexmedetomidine is a highly selective alpha-2 adrenoreceptor agonist that provides sedation, anxiolysis, and analgesic effects without causing respiratory depression. Aims and Objectives: The aim of the study was to compare intranasally administered dexmedetomidine and oral midazolam for premedication in pediatric patients undergoing cochlear implant surgeries. Materials and Methods: This prospective randomized controlled study included 60 ASA Grade I and II patients between 1 and 6 years of age who underwent cochlear implant surgeries under general anesthesia. Patients were divided into two groups. Group A received 1μg/kg intranasal dexmedetomidine and Group B patients received 0.5 mg/kg oral midazolam 45 min before induction. The pediatric separation anxiety was assessed using the pediatric separation anxiety scale (PSAS) while shifting the patient to operating room (OR) and mask acceptance was assessed by the attending anesthesiologist using mask acceptance scale (MAS) in OR who is blinded to the drug given. Heart rate (HR) and oxygen saturation were monitored till the end of procedure was noted on a pre-structured proforma. Results: The mean PSAS in intranasal dexmedetomidine group was 1.00±0.00, while in the oral midazolam group was 2.10±0.31 (P=0.000). The mean MAS in intranasal dexmedetomidine group was 1.00±0.00, while in the oral midazolam group was 2.13±0.35 (P=0.000). Mean HR (P>0.05), systolic blood pressure (P>0.05), and diastolic blood pressure (P>0.05) were comparable between both the groups. There was a statistically significant association seen between sedation grade and the groups (P=0.000), showing that groups are dependent on the sedation group. There was a statistically significant association seen between wake up behavior grade and the groups (P=0.000), showing that groups are dependent on the wake up behavior grade. Conclusion: Intranasal dexmedetomidine is an effective and safe alternative for premedication in view of parental separation, mask acceptance, hemodynamic stability, and sedation for the children undergoing cochlear implant surgeries under general anesthesia.
Title: Comparison of intranasal dexmedetomidine and oral midazolam as premedication for cochlear implant surgery in children
Description:
Background: Children undergoing surgical procedures can experience significant anxiety and distress during the perioperative period.
The use of sedative premedication may help to reduce anxiety, minimize the emotional trauma, and facilitate a smooth induction of anesthesia.
Midazolam is most commonly used as a premedication agent in children.
Dexmedetomidine is a highly selective alpha-2 adrenoreceptor agonist that provides sedation, anxiolysis, and analgesic effects without causing respiratory depression.
Aims and Objectives: The aim of the study was to compare intranasally administered dexmedetomidine and oral midazolam for premedication in pediatric patients undergoing cochlear implant surgeries.
Materials and Methods: This prospective randomized controlled study included 60 ASA Grade I and II patients between 1 and 6 years of age who underwent cochlear implant surgeries under general anesthesia.
Patients were divided into two groups.
Group A received 1μg/kg intranasal dexmedetomidine and Group B patients received 0.
5 mg/kg oral midazolam 45 min before induction.
The pediatric separation anxiety was assessed using the pediatric separation anxiety scale (PSAS) while shifting the patient to operating room (OR) and mask acceptance was assessed by the attending anesthesiologist using mask acceptance scale (MAS) in OR who is blinded to the drug given.
Heart rate (HR) and oxygen saturation were monitored till the end of procedure was noted on a pre-structured proforma.
Results: The mean PSAS in intranasal dexmedetomidine group was 1.
00±0.
00, while in the oral midazolam group was 2.
10±0.
31 (P=0.
000).
The mean MAS in intranasal dexmedetomidine group was 1.
00±0.
00, while in the oral midazolam group was 2.
13±0.
35 (P=0.
000).
Mean HR (P>0.
05), systolic blood pressure (P>0.
05), and diastolic blood pressure (P>0.
05) were comparable between both the groups.
There was a statistically significant association seen between sedation grade and the groups (P=0.
000), showing that groups are dependent on the sedation group.
There was a statistically significant association seen between wake up behavior grade and the groups (P=0.
000), showing that groups are dependent on the wake up behavior grade.
Conclusion: Intranasal dexmedetomidine is an effective and safe alternative for premedication in view of parental separation, mask acceptance, hemodynamic stability, and sedation for the children undergoing cochlear implant surgeries under general anesthesia.

Related Results

Midazolam for sedation before procedures in adults and children: a systematic review update
Midazolam for sedation before procedures in adults and children: a systematic review update
Abstract Background Midazolam is used for sedation before diagnostic and therapeutic medical procedures by several routes including oral, intravenou...
Comparing intrathecal dexmedetomidine versus midazolam in orthopedic cancer surgeries: a prospective randomized controlled trial
Comparing intrathecal dexmedetomidine versus midazolam in orthopedic cancer surgeries: a prospective randomized controlled trial
Background & objectives: The anesthetists have been trying various adjuvants with local anesthetic agents for spinal anesthesia to prolong the duration of analgesia and to redu...
EVALUATION OF INTRANASAL MIDAZOLAM AS PREANESTHETIC MEDICATION FOR BRIEF PEDIATRIC SURGICAL PROCEDURES
EVALUATION OF INTRANASAL MIDAZOLAM AS PREANESTHETIC MEDICATION FOR BRIEF PEDIATRIC SURGICAL PROCEDURES
Background: Operation theatres environment, surgery and anesthesia causes stress and anxiety. This can cause psychological disturbances especially in children. Sedative and anxioly...
Intramuscular Dexmedetomidine Versus Midazolam as a Premedication Before Surgery
Intramuscular Dexmedetomidine Versus Midazolam as a Premedication Before Surgery
Getting comfort and solace is an increasingly important idea in 21st century. The getting of progressing development and capacities directly deals with an unrivaled choice for pedi...
Dexmedetomidine vs midazolam for premedication of pediatric patients undergoing anesthesia
Dexmedetomidine vs midazolam for premedication of pediatric patients undergoing anesthesia
SummaryBackground:  Dexmedetomidine, an α2‐receptor agonist, provides sedation, analgesia, and anxiolytic effects, and these properties make it a potentially useful anesthetic prem...
Dexmedetomidine Intranasal sebagai Premedikasi pada Pediatri
Dexmedetomidine Intranasal sebagai Premedikasi pada Pediatri
Pendahuluan: Pembedahan merupakan pengalaman yang sangat menegangkan bagi pasien terutama bagi anak-anak, karena anak yang paling rentan terhadap ketakutan, kecemasan dan stres, ha...

Back to Top